May 21, 2019 / 03:00PM GMT
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Thanks, everybody, for joining us for our next session. I'm Matt Taylor, the U.S. medical supplies and devices analyst here at UBS. And we're really pleased to be joined by management from Abbott Laboratories. So with me onstage here is Brian Yoor, the EVP and President of Finance and Chief Financial Officer of Abbott. He's been in that position since February 2017. He previously served as SVP Finance and has been in Abbott since August 1997, so long tenure for the entire team here.
So Brian, to start out, we're going to do a fireside chat, but I want to give you a chance to talk about Abbott's diversified growth model and how that's helping you to deliver top tier organic growth here in the medical device space. So let's start with that one, then we'll get into some questions.
Brian B. Yoor - Abbott Laboratories - Executive VP of Finance & CFO
All right, sounds good, Matt. Thanks for having me here today. As we talk about
Abbott Laboratories at UBS Global Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers